Skip to content

Kestra Medical Technologies, Ltd.

KMTS

CIK 0001877184

← back to feed
Revenue (TTM)
$81.58M
+115.1% YoY Q3 Mar 2026
Net Income (TTM)
−$114.29M
−20.9% YoY Q3 Mar 2026
EPS Diluted (TTM)
−$3.00
−1.2% YoY Q3 Mar 2026
Gross Margin
48.7%
Q3 Mar 2026
Operating Margin
-142.2%
Q3 Mar 2026
Net Margin
-140.1%
Q3 Mar 2026
Free Cash Flow (TTM)
−$100.54M
Q3 Mar 2026
Cash
$291.32M
Q3 Mar 2026
Total Debt
$42.26M
Q3 Mar 2026
Shares Outstanding
58.37M sh
Q3 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings